Companies: 10,795·Total market cap: $144.5T
Annovis Bio, Inc.

Annovis Bio, Inc.

ANVSNYSEHealthcare● Active
$1.79
$-0.10(-5.29%)
Market Cap$35215771
P/E Ratio—
52W High$5.5
52W Low$1.54
Overview

Annovis Bio, Inc.（ANVS）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ANVS · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)—————
Operating Expenses
R&D Expenses$0.03B$0.02B$0.04B$0.02B$0.01B
G&A Expenses$0.00B$0.01B$0.01B$0.01B$0.01B
Total Operating Expenses$0.03B$0.03B$0.05B$0.03B$0.01B
Operating Income($0.03B)($0.03B)($0.05B)($0.03B)($0.01B)
Operating Margin %(computed)—————
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.03B)($0.02B)($0.06B)($0.03B)($0.01B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.03B)($0.02B)($0.06B)($0.03B)($0.01B)
Net Margin %(computed)—————
Per Share & EBITDA
EPS (Basic)$-1.40$-2018.50$-6.23$-3.10$-1.90
Wtd Avg Shares0.02B0.01B0.01B0.01B0.01B
EBITDA($0.03B)($0.03B)($0.05B)($0.03B)($0.01B)
EBITDA Margin %(computed)—————

数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B

查看SEC 10-K →查看SEC 10-Q →

深入了解Annovis Bio, Inc.

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

关于Annovis Bio, Inc.（ANVS）损益表

Annovis Bio, Inc.（ANVS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ANVS实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.03B)（净利率—）。

常见问题

ANVS · 4 问

Annovis Bio, Inc.（ANVS）2025财年营收为$0.00B，同比down—%。

ANVS revenueANVS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09